(Buenos Aires, Argentina)
Medical Doctor graduated at Universidad de Buenos Aires, Argentina, specialized in Pediatric Neurology. Head of Child Neurology Department at Hospital Universitario Austral. Buenos Aires. Argentina. Dr Amartino was trained in the field of inborn errors of metabolism at the Laboratorio de Neuroquimica by Dr Nestor Chamoles, in Buenos Aires. He has long term experience in Argentina with ERT for Fabry, Pompe and MPS. He is author of over 40 publications including books, book chapters and peer review journal articles. He is currently Principal Investigator in clinical trials for LSDs and co-director of PREIEM, an intensive training program on Mucopolysacharidosis for Latinoamerican physicians. He is also member of the following international boards related to LSDs: Pompe Registry Latam and International Boards, HOS (Hunter Outcome Survey) Latam Board, HOS CNS Task Force, and MPS IT Therapy Advisory Board.
Professor of Pediatrics and Genetics, University of Mainz, Germany. Former head of Lysosomal Storage Disorders at the Children's Hospital, University of Mainz and Head of the Biochemical Laboratory. Consultant at the Genetic Institute of the University of Mainz. Principal Investigator in a variety of clinical studies and trials in the field of Lysosomal Storage Disorders (Natural History, Enzyme Replacement Therapy). Organizer of the 3rd (1993) and 8th (2004) International Symposium on Mucopolysaccharidoses and Related Diseases. Author of more than 300 Articles, mostly in peer-reviewed international journals.
MD degree obtained at Universidad de Oriente, Venezuela, and PhD degree at Universidad de Guadalajara, México. Post-Doctoral training at Baylor College of Medicine, Houston, Texas. Chairman of the Department of Genetics, Instituto Mexicano del Seguro Social, Guadalajara, México. Professor at the PhD Program of Human Genetics, Universidad de Guadalajara, México.
(Porto Alegre, Brazil)
Professor at the Department of Genetics, Federal University of Rio Grande do Sul, and member of the Medical Genetics Service of Hospital de Clinicas de Porto Alegre, Brazil. Is also Coordinator of the Brazilian Institute of Population Medical Genetics (INAGEMP), Director of the WHO Collaborating Centre for the Development of Medical Genetics Services in Latin America, Chairman of the Latin American School of Human and Medical Genetics, and Editor-in-Chief of the Journal of Inborn Errors of Metabolism and Screening. Is past-President of the Latin American Network of Human Genetics (RELAGH), Brazilian Society of Medical Genetics (SBGM) and Latin American Society of Inborn Errors of Metabolism and Newborn Screening (SLEIMPN).